Margaret K. KyleChair, Intellectual Property and Markets for Technology, MINES ParisTech and Affiliated Expert at Cornerstone Research
Margaret Kyle is a noted authority on competition and intellectual property in the pharmaceutical industry. Her research includes the role of geographic and academic spillovers in R&D productivity, firm-specific and policy determinants of the distribution of new products, and competition from generic drugs. Women@Competition named Professor Kyle among forty notable women competition professionals in their forties.
In her recent work, Professor Kyle has examined the impact of trade and intellectual property policies on R&D investment and competition. In the context of COVID-19, she has analyzed how incentives can promote the development of new medical technologies and advance the rapid manufacture of tests and treatments.
Professor Kyle consults to policy entities on competition, economics, and innovation topics. She is a member of DG Competition’s Economic Advisory Group on Competition Policy. At France’s Conseil National de Productivité, which advises the French Prime Minister and the Minister of Economic Affairs, she is one of eleven independent academic economists analyzing the country’s productivity and competitiveness, particularly issues linked to the Euro Zone. In this capacity, she has coauthored work on policies to encourage pharmaceutical innovation. In the UK, Professor Kyle serves on the Research Committee for the Oﬃce of Health Economics.
Professor Kyle is a research fellow at the Centre for Economic Policy Research (CEPR). Her academic papers have been published in economics, strategy, and health policy journals, including the RAND Journal of Economics, the Review of Economics and Statistics, the Journal of Law and Economics, the Strategic Management Journal, Health Services Research, and Health Affairs. She is associate editor of the International Journal of Industrial Organization.
Professor Kyle has coauthored chapters in the Handbook of Health Economics, the Oxford Handbook of the Economics of the Biopharmaceutical Industry and Elsevier’s Encyclopedia of Health Economics.
Her previous positions include visiting professor of strategy at Northwestern University’s Kellogg School of Management; professor at the University of Toulouse and the Toulouse School of Economics; assistant professor at the London Business School; visiting professor at the University of Hong Kong; and visiting scholar at the Center for the Study of Income and Productivity at the U.S. Federal Reserve Bank of San Francisco.